The Role of FOXA Family Transcription Factors in Glucolipid Metabolism and NAFLD

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Feb 17

PMID 36798663

Authors

Chuchu Yu

Xiaojing Li

Yu Zhao

Yiyang Hu

Affiliations

Soon will be listed here.

Abstract

Abnormal glucose metabolism and lipid metabolism are common pathological processes in many metabolic diseases, such as nonalcoholic fatty liver disease (NAFLD). Many studies have shown that the forkhead box (FOX) protein subfamily FOXA has a role in regulating glucolipid metabolism and is closely related to hepatic steatosis and NAFLD. FOXA exhibits a wide range of functions ranging from the initiation steps of metabolism such as the development of the corresponding metabolic organs and the differentiation of cells, to multiple pathways of glucolipid metabolism, to end-of-life problems of metabolism such as age-related obesity. The purpose of this article is to review and discuss the currently known targets and signal transduction pathways of FOXA in glucolipid metabolism. To provide more experimental evidence and basis for further research and clinical application of FOXA in the regulation of glucolipid metabolism and the prevention and treatment of NAFLD.

Citing Articles

Novel Therapeutic Target for ALI/ARDS: Forkhead Box Transcription Factors.

Zhu X, Meng L, Xu L, Hua Y, Feng J Lung. 2024; 202(5):513-522.

PMID: 39259274 DOI: 10.1007/s00408-024-00740-z.

Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells.

Qiu Z, Huang L, Wang X, Wang Z, Li X, Feng B J Clin Transl Hepatol. 2024; 12(7):659-666.

PMID: 38993508 PMC: 11233981. DOI: 10.14218/JCTH.2023.00531.

An integrated analysis of the anticarcinogenic role of forkhead box protein 1 in oesophageal squamous cell carcinoma.

Ye G, Pan G, Zhu X, Li N, Liu H, Geng G J Cell Mol Med. 2024; 28(8):e18294.

PMID: 38652109 PMC: 11037412. DOI: 10.1111/jcmm.18294.

FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.

Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.

PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases.

Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y Signal Transduct Target Ther. 2024; 9(1):50.

PMID: 38424050 PMC: 10904817. DOI: 10.1038/s41392-024-01756-w.

References

Balsalobre A, Drouin J . Pioneer factors as master regulators of the epigenome and cell fate. Nat Rev Mol Cell Biol. 2022; 23(7):449-464. DOI: 10.1038/s41580-022-00464-z. View

Hannenhalli S, Kaestner K . The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009; 10(4):233-40. PMC: 2733165. DOI: 10.1038/nrg2523. View

Vatamaniuk M, Gupta R, Lantz K, Doliba N, Matschinsky F, Kaestner K . Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. Diabetes. 2006; 55(10):2730-6. DOI: 10.2337/db05-0470. View

Gao B, Xie W, Wu X, Wang L, Guo J . Functionally analyzing the important roles of hepatocyte nuclear factor 3 (FoxA) in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2020; 1873(2):188365. DOI: 10.1016/j.bbcan.2020.188365. View

Khalifa O, Al-Akl N, Errafii K, Arredouani A . Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway. Sci Rep. 2022; 12(1):2226. PMC: 8828858. DOI: 10.1038/s41598-022-06143-5. View

Wolfrum C, Asilmaz E, Luca E, Friedman J, Stoffel M . Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 2004; 432(7020):1027-32. DOI: 10.1038/nature03047. View

Bechmann L, Hannivoort R, Gerken G, Hotamisligil G, Trauner M, Canbay A . The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2011; 56(4):952-64. DOI: 10.1016/j.jhep.2011.08.025. View

Jiao N, Baker S, Chapa-Rodriguez A, Liu W, Nugent C, Tsompana M . Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2017; 67(10):1881-1891. DOI: 10.1136/gutjnl-2017-314307. View

von Meyenn F, Porstmann T, Gasser E, Selevsek N, Schmidt A, Aebersold R . Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab. 2013; 17(3):436-47. DOI: 10.1016/j.cmet.2013.01.014. View

10.

Fujimori K, Amano F . Forkhead transcription factor Foxa1 is a novel target gene of C/EBPβ and suppresses the early phase of adipogenesis. Gene. 2010; 473(2):150-6. DOI: 10.1016/j.gene.2010.12.002. View

11.

Li J, Jiang R, Cong X, Zhao Y . UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer. FEBS Lett. 2019; 593(18):2525-2534. DOI: 10.1002/1873-3468.13546. View

12.

Lau H, Ng N, Loo L, Jasmen J, Teo A . The molecular functions of hepatocyte nuclear factors - In and beyond the liver. J Hepatol. 2017; 68(5):1033-1048. DOI: 10.1016/j.jhep.2017.11.026. View

13.

Li Y, Xu Y, Jadhav K, Zhu Y, Yin L, Zhang Y . Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis. Arterioscler Thromb Vasc Biol. 2019; 39(8):1574-1587. PMC: 6656627. DOI: 10.1161/ATVBAHA.119.312610. View

14.

Dai X, Cheng H, Chen X, Li T, Zhang J, Jin G . FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing and . Int J Biol Sci. 2019; 15(5):1030-1041. PMC: 6535797. DOI: 10.7150/ijbs.31009. View

15.

Aghadi M, Elgendy R, Abdelalim E . Loss of FOXA2 induces ER stress and hepatic steatosis and alters developmental gene expression in human iPSC-derived hepatocytes. Cell Death Dis. 2022; 13(8):713. PMC: 9381545. DOI: 10.1038/s41419-022-05158-0. View

16.

Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B . Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018; 69(4):927-947. DOI: 10.1016/j.jhep.2018.06.008. View

17.

Chen Q, Yang X, Zhang H, Kong X, Yao L, Cui X . Metformin impairs systemic bile acid homeostasis through regulating SIRT1 protein levels. Biochim Biophys Acta Mol Cell Res. 2016; 1864(1):101-112. DOI: 10.1016/j.bbamcr.2016.10.020. View

18.

Liu Y, Shen W, Brubaker P, Kaestner K, Drucker D . Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression. Biochem J. 2002; 366(Pt 2):633-41. PMC: 1222783. DOI: 10.1042/BJ20020095. View

19.

Yalley A, Schill D, Hatta M, Johnson N, Cirillo L . Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes. J Biol Chem. 2016; 291(16):8848-61. PMC: 4861452. DOI: 10.1074/jbc.M115.677583. View

20.

Loomba R, Friedman S, Shulman G . Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021; 184(10):2537-2564. DOI: 10.1016/j.cell.2021.04.015. View